biocrates life sciences ag becomes part of Bruker Group

Bruker Corporation has announced the full acquisition of biocrates life sciences ag. biocrates, located in Innsbruck, Austria is the global leader in mass spectrometry-based quantitative metabolite and lipid analysis, offering kits, software, and services that make standardized metabolomics accessible.

biocrates life sciences ag has been consistently backed by MIG and ARAX Funds in developing its core technologies that are now used by hundreds of laboratories worldwide. biocrates has grown into a category leader in the science of metabolomics, enabling researchers to measure more than 1,800 biomarkers from a single drop of blood.

Dr. Sebastian Gottfried, CMO of biocrates, commented, “Their support, insight, and belief in our mission were instrumental in getting us to this point. We’re excited about what lies ahead with Bruker, and we thank MIG and ARAX Funds and their respective investors for their role in helping us reach this milestone.”

“Joining Bruker is a major milestone and a strong validation of our team’s hard work and vision”, added Moritz Seuster, CEO of biocrates. “What makes this partnership so powerful is our shared passion for multiomics and biocrates’ continued commitment to supporting and innovating across multiple MS technologies and vendors. With Bruker, we’re poised to scale our impact while staying true to our mission to make omics quantitative, reproducible, and easily accessible. We’re deeply thankful to our employees, customers, and partners who made this possible.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>